Silence Therapeutics, Plc. revenue breakdown overview

Silence Therapeutics, Plc. revenue for the last year amounted to 42.86 M USD, the most of which — 42.35 M USD — came from its highest performing source at the moment, Ribonucleic Acid Therapeutics, the year earlier bringing 32.30 M USD. The greatest contribution to the revenue figure was made by United Kingdom — last year it brought Silence Therapeutics, Plc. 42.21 M USD, and the year before that — 31.58 M USD.